In summary, we demonstrated that LINE-1 methylation levels in primary and secondary GBMs are lower than those in LGGs and normal brain tissues, that LINE-1 methylation is directly proportional to MGMT promoter methylation in gliomas, and that higher LINE-1 methylation is a favorable prognostic factor in primary GBMs. This evidence concerns the gene MGMT and glioma.